Point-of-care glucose and hemoglobin A1c in emergency department patients without known diabetes: Implications for opportunistic screening

Academic Emergency Medicine

Volumn 15, Issue 12, 2008, Pages 1241-1247

  Ginde, Adit A ^a,b   Cagliero, Enrico ^c   Nathan, David M ^c   Camargo Jr , Carlos A ^c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Diabetes; Emergency medicine; Glucose; Hemoglobin A1c; Public health; Screening

Indexed keywords

CORTICOSTEROID; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; DIAGNOSTIC ACCURACY; DRUG USE; EMERGENCY WARD; FEMALE; FOLLOW UP; GENDER; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OUTPATIENT CARE; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; SCREENING; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BLOOD GLUCOSE; BODY MASS INDEX; BOSTON; CONTINENTAL POPULATION GROUPS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; EMERGENCY SERVICE, HOSPITAL; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; POINT-OF-CARE SYSTEMS; SOCIOECONOMIC FACTORS; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 57349164417     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1553-2712.2008.00240.x     Document Type: Article

References (27)

1. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2005. Rev ed. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2005.
2. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the US population. Diabetes Care. 2006; 29:1263-8.
3. Harris MI, Klein R, Welborn TA, Knullman MW. Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care. 1992; 15:815-9.
4. Ealovega MW, Tabaei BP, Brandle M, Burke R, Herman WH. Opportunistic screening for diabetes in routine medical practice. Diabetes Care. 2004; 27:9-12.
5. Tabaei BP, Burke R, Constance A, et al. Community-based screening for diabetes in Michigan. Diabetes Care. 2003; 26:668-70.
6. Rolka DB, Narayan KM, Thompson TJ, et al. Performance of recommended screening tests for undiagnosed diabetes and dysglycemia. Diabetes Care. 2001; 24:1899-903.
7. Ginde AA, Delaney KE, Lieberman RM, Vanderweil SG, Camargo CA Jr. Estimated risk for undiagnosed diabetes in the emergency department: a multicenter survey. Acad Emerg Med. 2007; 14:492-5.
8. Silverman RA, Pahk R, Carbone M, et al. The relationship of plasma glucose and hbA1c levels among emergency department patients with no prior history of diabetes mellitus. Acad Emerg Med. 2006; 13:722-6.
9. Nawar EW, Niska RW, Xu J. National Hospital Ambulatory Medical Care Survey: 2005 emergency department summary. Adv Data. 2007; 386:1-32.
10. Ginde AA, Delaney KE, Lieberman RM, Vanderweil S, Camargo CA Jr. Estimated risk for undiagnosed diabetes in the emergency department: a multicenter survey. Acad Emerg Med. 2007; 14:492-5.
11. Peters AL, Davidson MB, Schriger DL, Hasselblad V. A clinical approach for the diagnosis of diabetes mellitus: An analysis using glycosylated hemoglobin levels. JAMA. 1996; 276:1246-52.
12. Rohlfing CL, Little RR, Wiedmeyer HM, Brown MB. Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care. 2000; 23:187-91.
13. Davidson MB, Schriger DL, Peters AL, Lorber B. Relationship between fasting plasma glucose and glycosylated hemoglobin: Potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA. 1999; 281:1203-10.
14. American Diabetes Association. Classification and diagnosis of diabetes mellitus. Diabetes Care. 2008; 31(Suppl 1):S55-60.
15. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1:307-10.
16. Mattewal A, Aldasouqi S, Solomon D, Gossain V, Koller A. A1cNow® InView™: a new simple method for office-based glycohemoglobin measurement. J Diabetes Sci Technol. 2007; 1:879-84.
17. Baker DW, Stevens CD, Brook RH. Regular source of ambulatory care and medical care utilization by patients presenting to a public hospital emergency department. JAMA. 1994; 271:1909-12.
18. Bernstein SL, Haukoos JS. Public health, prevention, and emergency medicine: a critical juxtaposition. Acad Emerg Med. 2008; 15:190-3.
19. Irvin CB, Wyer PC, Gerson LW. Preventive care in the emergency department, part II: clinical preventive services-an evidence-based review. Acad Emerg Med. 2000; 7:1042-54.
20. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329:977-86.
21. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352:837-53.
22. Woerle HF, Pimenta WP, Meyer C, et al. Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin A1c values. Arch Intern Med. 2004; 164:1627-32.
23. Backer HD, Decker L, Ackerson L. Reproducibility of increased blood pressure during an emergency department or urgent care visit. Ann Emerg Med. 2003; 41:507-12.
24. Karras DJ, Kruus LK, Cienki JJ, et al. Evaluation and treatment of patients with severely elevated blood pressure in academic emergency departments: a multicenter study. Ann Emerg Med. 2006; 47:230-6.
25. Tilman K, DeLashaw M, Lowe S, Springer S, Hundley S, Counselman FL. Recognizing asymptomatic elevated blood pressure in ED patients: how good (bad) are we? Am J Emerg Med. 2007; 25:313-7.
26. Slovis CM, Reddi AS. Increased blood pressure without evidence of acute end organ damage. Ann Emerg Med. 2008; 51:S7-9.
27. Waugh N, Scotland G, McNamee P, et al. Screening for type-2 diabetes: literature review and economic modeling. Health Technol Assess. 2007; 11:1-125.